Literature DB >> 17980878

Abnormal preconception oral glucose tolerance test predicts an unfavorable pregnancy outcome after an in vitro fertilization cycle.

Hsiao-Jui Wei1, Robert Young, I-Li Kuo, Chian-Mey Liaw, Han-Sun Chiang, Ching-Ying Yeh.   

Abstract

OBJECTIVE: To determine the relationship between the 75-g oral glucose tolerance test and pregnancy outcome after women's first IVF cycle.
DESIGN: Prospective study.
SETTING: Infertility center at a private tertiary hospital in Taiwan. PATIENT(S): All 280 patients who went through their initial IVF cycle at the hospital between January 2004 and April 2005 were included in the study. INTERVENTION(S): Two hundred eighty patients underwent an oral glucose tolerance test before entering an IVF cycle; all pregnancy outcomes and pregnancy complications were recorded. MAIN OUTCOME MEASURE(S): The relationships between glycemic parameters and insulin resistance and IVF pregnancy outcome were determined. Linear regression between birth weight and levels of preconception fasting insulin, 2-hour glucose, and 2-hour insulin was performed. RESULT(S): One hundred twenty patients conceived after their initial IVF cycle. Twenty-five of 89 ongoing pregnancies had various complications. The most common pregnancy complication was preterm birth (n = 11). These patients had higher body mass index (23.46 vs. 20.97 kg/m(2)); higher fasting glucose (107.36 vs. 95.14 mg/dL), fasting insulin (10.55 vs. 6.20 microIU/mL), and 2-hour glucose (120.55 vs. 99.97 mg/dL) levels; and higher homeostatic model assessment of insulin resistance (3.43 vs. 1.45) than did patients with full-term pregnancies. Linear regression between birth weight and the fasting glucose level and between birth weight and the homeostatic model assessment of insulin resistance had positive correlations. CONCLUSION(S): Before proceeding with IVF, preconception oral glucose tolerance testing is suggested, especially in patients with higher body mass index, to help identify groups who are at high risk for preterm birth.

Entities:  

Mesh:

Year:  2007        PMID: 17980878     DOI: 10.1016/j.fertnstert.2007.07.1289

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

2.  Racial and ethnic disparities in assisted reproductive technology outcomes in the United States.

Authors:  Victor Y Fujimoto; Barbara Luke; Morton B Brown; Tarun Jain; Alicia Armstrong; David A Grainger; Mark D Hornstein
Journal:  Fertil Steril       Date:  2008-12-10       Impact factor: 7.329

Review 3.  Insulin resistance in women's health: why it matters and how to identify it.

Authors:  Richard S Legro
Journal:  Curr Opin Obstet Gynecol       Date:  2009-08       Impact factor: 1.927

4.  Preconception hemoglobin A1c concentration in healthy women is not associated with fecundability or pregnancy loss.

Authors:  Jessica R Zolton; Lindsey A Sjaarda; Sunni L Mumford; Tiffany L Holland; Keewan Kim; Kerry S Flannagan; Samrawit F Yisahak; Stefanie N Hinkle; Matthew T Connell; Mark V White; Neil J Perkins; Robert M Silver; Micah J Hill; Alan H DeCherney; Enrique F Schisterman
Journal:  F S Rep       Date:  2022-01-20

5.  Preconception risk assessment of infertile couples.

Authors:  Nafisehsadat Nekuei; Ashraf Kazemi; Soheila Ehsanpur; Nastaran Mohammad Ali Beigi
Journal:  Iran J Nurs Midwifery Res       Date:  2013-01

6.  Metabolic changes during pregnancy in glucose-intolerant NZO mice: A polygenic model with prediabetic metabolism.

Authors:  Katharina Grupe; Melissa Asuaje Pfeifer; Franziska Dannehl; Moritz Liebmann; Ingo Rustenbeck; Annette Schürmann; Stephan Scherneck
Journal:  Physiol Rep       Date:  2020-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.